ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer

被引：0
|
作者：
Fenner A.
机构：
[1] Nature Reviews Urology,
来源：
Nature Reviews Urology | 2022年 / 19卷 / 11期
关键词：
D O I：
10.1038/s41585-022-00664-4
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：634 / 634
相关论文
共 50 条
  • [1] ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
    Devos, Gaetan
    Tosco, Lorenzo
    Baldewijns, Marcella
    Gevaert, Thomas
    Goffin, Karolien
    Petit, Valentin
    Mai, Cindy
    Laenen, Annouschka
    Raskin, Yannic
    Van Haute, Carl
    Goeman, Lieven
    De Meerleer, Gert
    Berghen, Charlien
    Devlies, Wout
    Claessens, Frank
    Van Poppel, Hendrik
    Everaerts, Wouter
    Joniau, Steven
    [J]. EUROPEAN UROLOGY, 2023, 83 (06) : 508 - 518
  • [2] Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
    Lorenzo Tosco
    Annouschka Laenen
    Thomas Gevaert
    Isabelle Salmon
    Christine Decaestecker
    Elai Davicioni
    Christine Buerki
    Frank Claessens
    Johan Swinnen
    Karolien Goffin
    Raymond Oyen
    Wouter Everaerts
    Lisa Moris
    Gert De Meerleer
    Karin Haustermans
    Steven Joniau
    [J]. BMC Cancer, 18
  • [3] Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
    Tosco, Lorenzo
    Laenen, Annouschka
    Gevaert, Thomas
    Salmon, Isabelle
    Decaestecker, Christine
    Davicioni, Elai
    Buerki, Christine
    Claessens, Frank
    Swinnen, Johan
    Goffin, Karolien
    Oyen, Raymond
    Everaerts, Wouter
    Moris, Lisa
    De Meerleer, Gert
    Haustermans, Karin
    Joniau, Steven
    [J]. BMC CANCER, 2018, 18
  • [4] ONCOLOGICAL OUTCOMES OF NEOADJUVANT DEGARELIX WITH APALUTAMIDE (ARNEO TRIAL) VERSUS STANDARD OF CARE PRIOR TO RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PROPENSITY SCORE MATCHED ANALYSIS
    Giesen, Alexander
    Devos, Gaetan
    Tosco, Lorenzo
    Baldewijns, Marcella
    Gevaert, Thomas
    Goffin, Karolien
    Valentin, Petit
    Cindy, Mai
    Yannic, Raskin
    Carl, Van Haute
    Goeman, Lieven
    Gert, De Meerleer
    Charlien, Berghen
    Wout, Devlies
    Frank, Claessens
    Hendrik, Van Poppel
    Wouter, Everaerts
    Steven, Joniau
    [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E1281 - E1281
  • [5] Three-year oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer
    Devos, G. T.
    Tosco, L.
    Baldewijns, M.
    Giesen, A.
    Gevaert, T.
    Goffin, K.
    Petit, V.
    Mai, C.
    Raskin, Y.
    Van Haute, C.
    De Meerleer, G.
    Berghen, C.
    Devlies, W.
    Van Poppel, H.
    Claessens, F.
    Everaerts, W.
    Joniau, S.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S1514 - S1514
  • [6] Two-year Quality of Life (QoL) outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer
    Giesen, A.
    Devos, G.
    Tosco, L.
    Baldewijns, M.
    Gevaert, T.
    Goffin, K.
    Petit, V.
    Mai, C.
    Raskin, Y.
    Van Haute, C.
    Goeman, L.
    De Meerleer, G.
    Berghen, C.
    Devlies, W.
    Claessens, F.
    Van Poppel, H.
    Everaerts, W.
    Joniau, S.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S1517 - S1518
  • [7] Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
    Devos, Gaetan
    Devlies, Wout
    De Meerleer, Gert
    Baldewijns, Marcella
    Gevaert, Thomas
    Moris, Lisa
    Milonas, Daimantas
    Van Poppel, Hendrik
    Berghen, Charlien
    Everaerts, Wouter
    Claessens, Frank
    Joniau, Steven
    [J]. NATURE REVIEWS UROLOGY, 2021, 18 (12) : 739 - 762
  • [8] Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
    Gaëtan Devos
    Wout Devlies
    Gert De Meerleer
    Marcella Baldewijns
    Thomas Gevaert
    Lisa Moris
    Daimantas Milonas
    Hendrik Van Poppel
    Charlien Berghen
    Wouter Everaerts
    Frank Claessens
    Steven Joniau
    [J]. Nature Reviews Urology, 2021, 18 : 739 - 762
  • [9] Neoadjuvant Therapy in High-Risk Prostate Cancer
    Ashrafi, Akbar N.
    Yip, Wesley
    Aron, Monish
    [J]. INDIAN JOURNAL OF UROLOGY, 2020, 36 (04) : 251 - 261
  • [10] Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer
    Febbo, PG
    Richie, JP
    George, DJ
    Loda, M
    Manola, J
    Shankar, S
    Barnes, AS
    Tempany, C
    Catalona, W
    Kantoff, PW
    Oh, WK
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5233 - 5240
12345